Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients

BACKGROUND: The purpose of this phase II study was to evaluate the safety and efficacy of weekly irinotecan and capecitabine (wXELIRI) treatment in patients with metastatic colorectal cancer, specifically the rate of severe diarrhea. METHODS: Patients with unresectable histologically confirmed metas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Li, Wenhua, Xu, Jianming, Shen, Lin, Liu, Tianshu, Guo, Weijian, Zhang, Wen, Chen, Zhiyu, Zhu, Xiaodong, Li, Jin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4300831/
https://ncbi.nlm.nih.gov/pubmed/25527007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-986
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados